Join Now

Utah Life Sciences News & Events

Co-Diagnostics, Inc. CEO to Participate in Panel Discussion with Scott Gottlieb, M.D., at H.C. Wainwright 2021 Annual Global Investor Conference

September 14, 2021

On September 13th, Co-Diagnostics, Inc. announced that Company CEO Dwight Egan will participate in a panel discussion hosted by Scott Gottlieb, M.D., titled “How We Can Defeat the Next Pandemic” at the H.C. Wainwright & Co. 2021 Global Investor Conference, being held virtually on September 13-15, 2021.

Dr. Gottlieb is the former Food and Drug Administration (FDA) Commissioner and former Centers for Medicare & Medicaid Services (CMS) Senior Advisor, and author of the upcoming book Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic. The panel will be conducted on September 15th at 12:00 pm ET and can be accessed by registering for the conference here.

Mr. Egan and Brian Brown, Co-Diagnostics CFO, will also be conducting a Healthcare & Biotech On-Demand presentation, which can be accessed on the Events and Webcasts section of the Co-Diagnostics website beginning on September 13, 2021 at 7:00 a.m. Eastern time.

For further information: Company Contact: Andrew Benson, Head of Investor Relations, +1 801-438-1036, investors@codiagnostics.com; or Investor Relations Contact: Zach Mizener, Lambert & Co., +1 616-233-0500, zmizener@lambert.com